Emergent BioSolutions Inc. — Director's Dealing 2012

Mar 30, 2012

SEC Form 4/A — Form 4/A

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2012-03-08

Reporting Person: El-Hibri Fuad (Director, CEO & Chairman, 10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	15845	Indirect
Common Stock	15845	Indirect
Common Stock	15845	Indirect

Footnotes

F1: This amendment on Form 4/A is being filed to correct an understatement of 76 shares in the amount of securities beneficially owned by the reporting person as reported on the Form 4 as originally filed on March 12, 2012. Other than the correction noted above, there were no changes to the disclosure in this Form 4/A. These shares were also understated in the one Form 4 filed by the reporting person after his original Form 4 was filed.

F2: These shares are held in a trust for the benefit of a child of the reporting person. The reporting person is trustee of this trust. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.